MYELINEASE™-P 75
MYELINEASE™-P 75
Pregabalin Sustained Release Tablets 75 mg
Sustained Relief for Neuropathic Pain
MYELINEASE™-P 75 by Levencare Life Sciences Pvt. Ltd. has Pregabalin 75 mg in Sustained Release (SR) form, especially intended for long-lasting relief from neuropathic pain. With its advanced delivery system, MYELINEASE™-P 75 delivers Pregabalin at a consistent rate over time, enabling the patient to maintain all-day pain control. Its development under high-quality standards embodies LevenCare’s mission of offering research-based, affordable treatments.
Key Features
Sustained Release Formulation
Long-Term Therapeutic Effect: The SR formulation permits slow release of Pregabalin, maintaining prolonged relief from pain and reducing the necessity of frequent administration.
Consistent Blood Levels: Assists in sustaining drug concentration at a consistent level, potentially alleviating peak-associated side effects.
WHO GMP-Certified Manufacturing
We are committed to procuring our products by WHO GMP certified selected and audited high tech manufacturing units of international standards.
Optimal Neuropathic Pain Management
Versatile Indications: Widely used for conditions like diabetic neuropathy, post-herpetic neuralgia, and fibromyalgia pain.
Patient-Centric: Designed to enhance patient compliance by decreasing dosing frequency.
Levencare Assurance
Our team has an experience in the industry of more than 20 years and we are driven by an objective of providing standardised and scientifically based products to our doctors and patients with exemplary display of professionalism and standard of conduct as per industry norms.
Ethical & Affordable: Dedicated to maintaining the highest standards while making it affordable and accessible to the masses.
Indications
Perfect for chronic nerve pain management, such as diabetic neuropathy, post-herpetic neuralgia, and fibromyalgia.
Adjunctive Therapy of Partial Seizures
Can be used in combination with other antiepileptic medications in certain seizure conditions (with a doctor’s guidance)
About Levencare Life Sciences Pvt. Ltd..
Established in 2022 and registered with the Registrar of Companies at Mumbai, LevenCare is driven by the spirit of selfless care. Our vision is to deliver world-class, research-oriented pharmaceutical and nutraceutical products at reasonable prices. Through partnerships with WHO GMP-approved manufacturing facilities, we ensure every product embodies our unshakeable commitment to quality, ethics, and patient welfare. We cater to various specialties—Obstetrics & Gynecology, Orthopaedics, Neurology, Medicine, Nephrology, and Gastroenterology—pursuing our mission of bringing advanced healthcare to everyone.
Our Vision
To prevent, preserve, and heal health disorders all over the world by providing peerless-quality, evidence-based, and affordable medicines. We are committed to our assurance of empowering healthcare professionals and patients with trusted solutions that meet the highest professional standards.
Dosage & Safety Information
Prescription Only:
MYELINEASE™-P 75 must be taken under the direction of a qualified medical practitioner.
Usual Dosage:
The dosage can differ according to the condition of the patient, intensity of symptoms, and clinical status. Always take the dosage as prescribed by your doctor and for as long as advised.
Possible Side Effects:
Could be dizziness, drowsiness, dry mouth, or weight changes. If you experience any extreme or lasting adverse effects, consult a doctor immediately.
Precautions:
Inform your doctor of any pre-existing medical conditions, particularly renal impairment, or if you are on other medication.
Exercise caution when driving or using machinery until you know how this drug will affect you.
Not to be used during pregnancy or lactation unless specifically directed by a healthcare provider.
Storage:
Store in a dry, cool place out of direct sunlight. Keep out of reach of children.
Experience the LevenCare Difference
Selecting MYELINEASE™-P 75 is to enjoy LevenCare’s dedication to quality, patient-focused care, and ongoing innovation. Have faith in our experience and commitment to assist healthcare professionals and patients in achieving effective, long-lasting relief from neuropathic pain.